Basic HTML Version
© The Canadian Journal of Urology™; 18(Supplement 1); April 2011
7
5. Gazzaruso C, Giordanetti S, De Amici E et al. Relationship
between erectile dysfunction and silent myocardial ischemia in
apparently uncomplicated type 2 diabetic patients.
Circulation
2004;110(1):22-26.
6. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank
AJ.
J Am Coll Cardiol
2004;43(2):179-184.
7. Montorsi F, Briganti A, Salonia et al. Erectile dysfunction
prevalence, time of onset and associationwith risk factors in 300
consecutive patients with acute chest pain and angiographically
documented coronary artery disease.
Eur Urol
2003;44(3):360-
365.
8. Brock GB. A simplified approach to the treatment of erectile
dysfunction-based on the CanadianUrologyAssociation erectile
dysfunction guidelines.
J Sex Reprod Med
2002;2:61-65.
9. Lue TF. Erectile dysfunction.
N Engl J Med
2000;342(24):1802-
1813.
10. Shabsigh R, Rajfer J, Aversa A et al. The evolving role of
testosterone in the treatment of erectile dysfunction.
Int J Clin
Pract
2006;60(9):1087-1092.
11. ZhangXH, Filippi S,MorelliAet al. Testosterone restoresdiabetes-
induced erectile dysfunction and sildenafil responsiveness in
two distinct animal models of chemical diabetes.
J Sex Med
2006;3(2):253-264.
12. Barkin J. Erectile dysfunction and low testosterone: cause or an
effect?
Can J Urol
2010;17(Suppl 1):2-11.
13. Viagra product monograph, March 31, 2009.
14. Cialis product monograph, March 5, 2009.
15. Levitra product monograph, August 26, 2009.
16. Montorsi F, Brock G, Lee J. Effect of nightly versus on-demand
vardenafil on recovery of erectile function in men following
bilateral nerve-sparing radical prostatectomy.
Eur Uro
l
2008;54(4):924-931.
17. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD,
Wicker PA. Oral sildenafil in the treatment of erectile dysfunction.
Sildenafil Study Group.
N Eng J Med
1998:338(20):1397-1404.
18. Benard F, Carrier S, Lee JC, Talwar V, Defoy I. Men with mild
erectile dysfunction benefit from sildenafil treatment.
J Sex Med
2010;7(11);3725-2735.
19. Lee JC, Benard F, Carrier S, Talwar V, Defoy I. Domenwithmild
erectile dysfunction have the same risk factors as the general
erectile dysfunction population?
BJU Int
2011;107(6):956-960.
20. Morley JE, Charlton E, Patrick P et al. Validation of a screening
questionnaire for androgen deficiency in agingmales.
Metabolism
2000;49(9):1239-1242.
21. Bhasin S, CunninghamGR, Hayes FJ et al. Testosterone therapy
in adult menwith androgen deficiency syndrome:An Endocrine
Society Clinical Practice Guideline.
J Clin Endocrinol Metab
2006;91(6):1995-2010
22. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone
levels in older adult men with diabetes mellitus.
Am J Epidemiol
1990;132(5):895-901.
23. Tan RS, Pu SJ. Impact of obesity on hypogonadism in the
andropause.
Int J Androl
2002;25(4):195-201.
24. Goodman-Gruen D, Barrett-Connor E.
Diabetes Care
2000;23(7):912-918.
25. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum
testosterone and mortality in older men.
J Clin Endocrinol Metab
2008;93(1):68-75.
26. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA,
Ostir GV.
J Am Geriatr Soc
2006;54(11):1666-1673.
27. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand
R;NorthAmericanAA2500 T Gel Study Group.
J Clin Endocrinol
Metab
2003;88(6):2673-2681.
28. Rhoden EL, Morgentaler A. Symptomatic response rates to
testosterone therapy and the likelihood of comleting 12 months
of therapy in clinical practice
J Sex Med
2010;7(1 Pt 1):277-283.
29. ZitzmannM. Testosterone and thebrain.
AgingMale
2006;9(4):195-
199.
30. Pope HG Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI.
Am J Psychiatry
2003;160(1):105-111.
31. Snyder PJ, Peachey H, Hannoush P et al. Effect of testosterone
treatment on bone mineral density in men over 65 years of age.
J Clin Endocrinol Metab
1999;84(6):1966-1972.
32. Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week
treatment with diet and exercise plus transdermal testosterone
reverses themetabolic syndrome and improves glycemic control
in men with newly diagnosed type 2 diabetes and subnormal
plasma testosterone.
J Androl
2009;30(6):726-733.
33. Malkin CJ, Pugh PJ, Morris PD et al. Testosterone replacement
in hypogonadal menwith angina improves ischaemic threshold
and quality of life.
Heart
2004;90(8):871-876.
34. Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects
of testosterone in men with chronic heart failure.
Eur Heart J
2003;24(10):909-915.
35. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer
KS. Testosterone therapy in men with moderate severity heart
failure: a double-blind randomized placebo controlled trial.
Eur
Heart J
2006;27(1):57-64.
36. Wang C, Cunningham G, Dobs A et al. Long-term testosterone
gel (AndroGel) treatment maintains beneficial effects on sexual
function andmood, lean and fat mass, and bonemineral density
in hypogonadal men.
J Clin Endocrinol Metab
2004;89(5):2085-
2098.
37. Jockenhovel F, Minnemann T, Schubert M et al. Comparison
of long-acting testosterone undecanoate formulation versus
testosterone enanthate on sexual function and mood in
hypogonadal man.
Eur J Endocrinol
2009;160(5):815-819.
38. Wang C, Swerdloff RS, Iranmanesh A et al. Transdermal
testosterone gel improves sexual function, mood, muscle
strength, and body composition parameters in hypogonaldal
men.
J Clin Endocrinol Metab
2000;85(8):2839-2853.
39. Prescribing information Depo-testosterone (testosterone
cypionate injection), August 2002.
40. Prescribing information Delatestryl (testosterone enanthate
solution for injection), June 14, 2007.
41. ProductmonographAndriol (testosterone undecoanate capsules,
December 15, 2008.
41. Prescribing information pms-Testosterone (testosterone
undecoanate capsules)]
43. MoralesA, Heaton JP, Carson CC 3rd. Andropause: a misnomer
for a true clinical entity.
J Urol
2000;163(3):705-712.
44. Hoffman MA, DeWolf WC, Morgentaler A. Is low serum free
testosterone a marker for high grade prostate cancer?
J Urol
2000;163(3):824-827.
45. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H.
Randomized study of testosterone gel as adjnctive therapy to
sildenafil in hypogonadal men with erectile dysfunction who
do not respond to sildenafil alone.
J Urol
2004;172(2):658-663.
46. Morley JE. Testosterone replacement in older men and women.
J Gend Specif Med
2001;4(2):49-53.
47. Vermeulen A. Diagnosis of partial androgen deficiency in the
aging male.
Ann Endocrinol (Paris)
2003;64(2):109-114.
Erectile dysfunction and hypogonadism (low testosterone)